Ishigami Masatoshi, Ishizu Yoji, Onishi Yasuharu, Kamei Hideya, Kiuchi Tetsuya, Itoh Akihiro, Hirooka Yoshiki, Katano Yoshiaki, Goto Hidemi
Department of Gastroenterology and Hepatology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, 466-8550 Nagoya, Japan.
Springerplus. 2013 Aug 7;2:374. doi: 10.1186/2193-1801-2-374. eCollection 2013.
Hypersplenism is a common complication in cirrhotic patients, and liver transplantation would be one of the effective treatments. However, detailed dynamics, especially over a long term, are not fully understood. We investigated the long-term dynamics of hematological data and spleen volumes, as well as their correlation in cirrhotic patients who underwent liver transplantation.
We studied 53 cirrhotic patients who underwent liver transplantation at our institute and followed for more than 1 year. Hematological data were collected from medical records, while spleen volumes were determined by CT volumetry at 0, 1, 3, 6, 12, 24, 36, 48, 60 postoperative months (POM).
(1) Platelet (Plt) and hemoglobin (Hb) levels were gradually increased up to 18 and 10 POM, respectively, in contrast with white blood cells (WBC), which remained mostly unchanged from pretransplantation levels. (2) Spleen volume was sharply decreased in the first POM, then showed a slower but steady decline up to 48 POM. (3) Spleen volume was significantly correlated with hematological data, though the levels were generally weak (Plt: r = 0.433, p < 0.001; Hb: r = 0.233, p < 0.001; WBC: r = 0.217, p = 0.001). (4) Spleen volume was strongly correlated with all hematological parameters in HBV patients (Plt: r = 0.617, p < 0.0001; Hb: r = 0.401, p < 0.001; WBC: r = 0.387, p < 0.001), in contrast with that in other etiologies, which had generally weak correlations though some were statistically significant.
We investigated the long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation. Unique dynamics and correlations between them were found among the different etiologies investigated.
脾功能亢进是肝硬化患者常见的并发症,肝移植是有效的治疗方法之一。然而,其详细动态变化,尤其是长期变化,尚未完全明确。我们研究了肝移植肝硬化患者血液学数据和脾脏体积的长期动态变化及其相关性。
我们对在我院接受肝移植且随访超过1年的53例肝硬化患者进行了研究。从病历中收集血液学数据,通过CT容积测量法在术后0、1、3、6、12、24、36、48、60个月(POM)测定脾脏体积。
(1)血小板(Plt)和血红蛋白(Hb)水平分别在术后18个月和10个月逐渐升高,而白细胞(WBC)与移植前水平相比基本保持不变。(2)脾脏体积在术后第1个月急剧下降,随后至48个月呈缓慢但稳定的下降趋势。(3)脾脏体积与血液学数据显著相关,尽管相关性一般较弱(Plt:r = 0.433,p < 0.001;Hb:r = 0.233,p < 0.001;WBC:r = 0.217,p = 0.001)。(4)脾脏体积与乙肝患者所有血液学参数均显著相关(Plt:r = 0.617,p < 0.0001;Hb:r = 0.401,p < 0.001;WBC:r = 0.387,p < 0.001),与其他病因患者相比,后者相关性一般较弱,尽管有些具有统计学意义。
我们研究了肝移植肝硬化患者血液学数据和脾脏体积的长期动态变化。在所研究的不同病因中发现了它们独特的动态变化及其相关性。